Thomas C. Hohman

Directeur/Bestuurslid bij Ocugenix Corp.

Health Services

Profiel

Thomas C.
Hohman is currently a Director at Ocugenix Corp.
and Galimedix Therapeutics, Inc. There is no additional information provided about his career history.

Actieve functies van Thomas C. Hohman

Bedrijven	Functie	Begin
Ocugenix Corp. Ocugenix Corp. Medical/Nursing ServicesHealth Services Ocugenix Corp. operates as a therapeutics company focusing on he development of of cancer immunotherapy drug for eye diseases. The company is headquartered in Pittsburgh, PA.	Directeur/Bestuurslid	-
Galimedix Therapeutics, Inc. (Maryland) Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer.	Directeur/Bestuurslid	-

Alle actieve functies van Thomas C. Hohman

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Thomas C. Hohman in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	2
Ocugenix Corp. Ocugenix Corp. Medical/Nursing ServicesHealth Services Ocugenix Corp. operates as a therapeutics company focusing on he development of of cancer immunotherapy drug for eye diseases. The company is headquartered in Pittsburgh, PA.	Health Services
Galimedix Therapeutics, Inc. (Maryland) Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer.	Health Services